Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.5K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

3.4K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
3.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rigid cystoscopy versus flexible outpatient cystoscopy: the economic cost behind the epidemiological and social impact.

Einstein (Sao Paulo, Brazil)·2026
Same author

Biochemical recurrence following definitive treatment of prostate cancer in Brazil: a retrospective cohort study.

BMC urology·2026
Same author

Clinical Recommendations for Remote Robotic Assisted Surgery From the CRSA 2025 International Consensus Conference.

World journal of surgery·2026
Same author

Reply to "comment on: Socioeconomic inequities in prostate cancer care: private versus public treatment settings pose a significant impact on overall survival".

Einstein (Sao Paulo, Brazil)·2026
Same author

Robotic retroperitoneal lymph node dissection: a stepwise technical guide.

Journal of robotic surgery·2026
Same author

Adrenal neuroblastoma in adult: case report.

Urology case reports·2026

Related Experiment Video

Updated: Nov 9, 2025

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

16.8K

Consensus on Prostate Cancer Treatment of Localized Disease With Very Low, Low, and Intermediate Risk: A Report From

Murilo de Almeida Luz1, Gustavo Cardoso Guimarães2, Aguinaldo César Nardi3

  • 1Hospital Erasto Gaertner, Curitiba, Brazil.

JCO Global Oncology
|April 15, 2021
PubMed
Summary

International experts developed consensus statements for managing early-stage prostate cancer (PCa) in developing nations. These recommendations focus on very low, low, and intermediate-risk PCa, offering guidance for resource-limited settings.

More Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.4K
Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

8.3K

Related Experiment Videos

Last Updated: Nov 9, 2025

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

16.8K
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.4K
Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

8.3K

Area of Science:

  • Urology
  • Medical Oncology
  • Global Health

Background:

  • Prostate cancer (PCa) management in developing countries lacks established guidelines.
  • Significant disparities exist in PCa diagnosis and treatment globally.
  • There is a need for evidence-based recommendations tailored to resource-limited settings.

Purpose of the Study:

  • To develop consensus statements for the management of very low-, low-, and intermediate-risk prostate cancer (PCa) specifically for developing countries.
  • To provide practical guidance for healthcare professionals facing PCa in resource-constrained environments.
  • To establish a reference point for clinical decision-making in the absence of formal guidelines.

Main Methods:

  • A survey was developed by international urology and medical oncology experts.
  • A panel of 99 international multidisciplinary cancer experts voted on 66 survey questions concerning PCa risk stratification.
  • Recommendations were based on anonymous voting, requiring 75% consensus, and considered cost-effectiveness and accessibility of therapies.

Main Results:

  • Consensus was reached on key aspects of treatment and follow-up for early-stage PCa.
  • Recommendations prioritize cost-effective and accessible therapeutic options suitable for developing countries.
  • The study generated actionable insights for managing PCa in areas with limited resources.

Conclusions:

  • The developed recommendations serve as a crucial reference for physicians managing PCa in developing countries.
  • These consensus statements aim to improve clinical decision-making for very low, low, and intermediate-risk PCa.
  • This initiative addresses a critical gap in prostate cancer care guidance for underserved populations.